A Smart Eli Lilly & Co. (LLY) Investor Does What Now?

Eli Lilly & Co. (NYSE:LLY) was in 35 hedge funds’ portfolio at the end of March. LLY investors should be aware of a decrease in hedge fund interest recently. There were 36 hedge funds in our database with LLY positions at the end of the previous quarter.

In the financial world, there are a multitude of metrics shareholders can use to track stocks. A pair of the most useful are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the top hedge fund managers can outperform the market by a very impressive margin (see just how much).

Equally as important, positive insider trading sentiment is another way to break down the stock market universe. There are lots of stimuli for an upper level exec to drop shares of his or her company, but just one, very obvious reason why they would buy. Plenty of empirical studies have demonstrated the impressive potential of this method if investors understand where to look (learn more here).

With these “truths” under our belt, we’re going to take a gander at the recent action surrounding Eli Lilly & Co. (NYSE:LLY).

How have hedgies been trading Eli Lilly & Co. (NYSE:LLY)?

At the end of the first quarter, a total of 35 of the hedge funds we track were long in this stock, a change of -3% from the previous quarter. With hedgies’ capital changing hands, there exists a select group of notable hedge fund managers who were boosting their stakes substantially.

Eli Lilly & Co. (NYSE:LLY)When looking at the hedgies we track, Renaissance Technologies, managed by Jim Simons, holds the most valuable position in Eli Lilly & Co. (NYSE:LLY). Renaissance Technologies has a $599.5 million position in the stock, comprising 1.5% of its 13F portfolio. The second largest stake is held by Peter Rathjens, Bruce Clarke and John Campbell of Arrowstreet Capital, with a $204.8 million position; the fund has 1.6% of its 13F portfolio invested in the stock. Remaining hedgies that are bullish include Cliff Asness’s AQR Capital Management, Stanley Druckenmiller’s Duquesne Capital and Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management.

Due to the fact that Eli Lilly & Co. (NYSE:LLY) has witnessed a declination in interest from hedge fund managers, it’s safe to say that there is a sect of hedge funds that decided to sell off their full holdings at the end of the first quarter. Intriguingly, Stephen DuBois’s Camber Capital Management sold off the biggest stake of the “upper crust” of funds we watch, totaling close to $49 million in call options, and Stephen DuBois of Camber Capital Management was right behind this move, as the fund dropped about $24.5 million worth. These transactions are intriguing to say the least, as aggregate hedge fund interest was cut by 1 funds at the end of the first quarter.

How are insiders trading Eli Lilly & Co. (NYSE:LLY)?

Insider trading activity, especially when it’s bullish, is particularly usable when the company we’re looking at has seen transactions within the past half-year. Over the last six-month time period, Eli Lilly & Co. (NYSE:LLY) has experienced zero unique insiders purchasing, and 7 insider sales (see the details of insider trades here).

With the returns exhibited by our tactics, everyday investors should always keep an eye on hedge fund and insider trading activity, and Eli Lilly & Co. (NYSE:LLY) applies perfectly to this mantra.

Click here to learn why you should track hedge funds

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!